These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 2383279

  • 1. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ, Marsh ER, Kula NS, Zong RS, Gao YG, Neumeyer JL.
    Biochem Pharmacol; 1990 Aug 01; 40(3):417-23. PubMed ID: 2383279
    [Abstract] [Full Text] [Related]

  • 2. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG, Baldessarini RJ, Kula NS, Gao Y, Zong R, Neumeyer JL.
    Mol Pharmacol; 1990 Jul 01; 38(1):92-101. PubMed ID: 1973525
    [Abstract] [Full Text] [Related]

  • 3. R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat.
    Campbell A, Baldessarini RJ, Gao Y, Zong R, Neumeyer JL.
    Neuropharmacology; 1990 Jun 01; 29(6):527-36. PubMed ID: 1974710
    [Abstract] [Full Text] [Related]

  • 4. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y, Fage D, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1985 Feb 01; 232(2):519-25. PubMed ID: 2857197
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system.
    Campbell A, Baldessarini RJ, Kula NS, Ram VJ, Neumeyer JL.
    Brain Res; 1987 Feb 17; 403(2):393-7. PubMed ID: 3828830
    [Abstract] [Full Text] [Related]

  • 7. Aporphines. 14 Dopaminergic and antinociceptive activity of aporphine derivatives. Synthesis of 10-hydroxyaporphines and 10-hydroxy-N-n-propylnoraporphine.
    Neumeyer JL, Reinhard JF, Dafeldecker WP, Guarino J, Kosersky DS, Fuxe K, Agnati L.
    J Med Chem; 1976 Jan 17; 19(1):25-9. PubMed ID: 942751
    [Abstract] [Full Text] [Related]

  • 8. Neuropharmacology and stereochemistry of dopamine receptor agonist and antagonist enantiomeric pairs.
    Neumeyer JL, Froimowitz M, Baldessarini RJ, Campbell A, Gao YG.
    J Recept Res; 1988 Jan 17; 8(1-4):83-96. PubMed ID: 3385694
    [Abstract] [Full Text] [Related]

  • 9. Selective antidopaminergic effects of S(+)N-n-propylnoraporphines in limbic versus extrapyramidal sites in rat brain: comparisons with typical and atypical antipsychotic agents.
    Campbell A, Yeghiayan S, Baldessarini RJ, Neumeyer JL.
    Psychopharmacology (Berl); 1991 Jan 17; 103(3):323-9. PubMed ID: 1676180
    [Abstract] [Full Text] [Related]

  • 10. Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine.
    Campbell A, Baldessarini RJ, Neumeyer JL.
    Psychopharmacology (Berl); 1993 Jan 17; 111(3):351-8. PubMed ID: 7870974
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and potency comparisons among aporphine enantiomers: effects on dopamine neurons in substantia nigra of rat.
    Martin LP, Cox RF, Waszczak BL.
    Neuropharmacology; 1990 Feb 17; 29(2):135-43. PubMed ID: 2184376
    [Abstract] [Full Text] [Related]

  • 12. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A, Rivet JM, Audinot V, Cistarelli L, Spedding M, Vian J, Peglion JL, Millan MJ.
    J Pharmacol Exp Ther; 1995 Nov 17; 275(2):899-913. PubMed ID: 7473181
    [Abstract] [Full Text] [Related]

  • 13. The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo.
    van Oene JC, de Vries JB, Horn AS.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct 17; 327(4):304-11. PubMed ID: 6514014
    [Abstract] [Full Text] [Related]

  • 14. Effects of isomers of apomorphines on dopamine receptors in striatal and limbic tissue of rat brain.
    Kula NS, Baldessarini RJ, Bromley S, Neumeyer JL.
    Life Sci; 1985 Sep 16; 37(11):1051-7. PubMed ID: 4033350
    [Abstract] [Full Text] [Related]

  • 15. Aporphines. 48. Enantioselectivity of (R)-(-)- and (S)-(+)-N-n-propylnorapomorphine on dopamine receptors.
    Neumeyer JL, Reischig D, Arana GW, Campbell A, Baldessarini RJ, Kula NS, Watling KJ.
    J Med Chem; 1983 Apr 16; 26(4):516-21. PubMed ID: 6682147
    [Abstract] [Full Text] [Related]

  • 16. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.
    Saller CF, Salama AI.
    Eur J Pharmacol; 1986 Feb 18; 121(2):181-8. PubMed ID: 3699091
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of dopamine synthesis in rat striatal minces: evidence of dopamine autoreceptor supersensitivity to S(+)- but not R(-)-N-n-propylnorapomorphine after pretreatment with fluphenazine.
    Booth RG, Baldessarini RJ, Campbell A.
    Biochem Pharmacol; 1991 Jun 15; 41(12):2040-3. PubMed ID: 1674873
    [Abstract] [Full Text] [Related]

  • 18. Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity.
    Lew JY, Garcia-Espana A, Lee KY, Carr KD, Goldstein M, Haycock JW, Meller E.
    Mol Pharmacol; 1999 Feb 15; 55(2):202-9. PubMed ID: 9927609
    [Abstract] [Full Text] [Related]

  • 19. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Feb 15; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 20. Behavioral effects of apomorphine isomers in the rat: selective locomotor-inhibitory effects of S(+)N-n-propylnorapomorphine.
    Campbell A, Baldessarini RJ, Teicher MH, Neumeyer JL.
    Psychopharmacology (Berl); 1986 Feb 15; 88(2):158-64. PubMed ID: 3081927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.